Trial intelligence / Profile preview

Adjuvant endocrine therapy with or without chemotherapy in node-positive hormone receptor-positive HER2-negative breast cancer with low-to-intermediate Oncotype DX recurrence score

2012-000174-37Phase 3Active

Sponsor

GEICAM

Start

Feb 2012

Modality

Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1